Trials for new HIV prevention drug showed 99.9% of participants remained negative

The U.S. Food and Drug Administration has approved a new HIV prevention medication that's been found to be highly effective. The drug is named Yeztugo by drug developer Gilead. CBS News medical contributor Dr. Celine Gounder has more.